Skip to main content

Table 1 Comparison of different variables between study groups

From: Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease

Variables

Control n = 35

CKD stage G4 n = 48

CKD stage G5 n = 35

CKD stage G5D n = 70

Age (years)

75.1 ± 6.5

77.1 ± 9.0

75.3 ± 8.9

73.1 ± 8.5

Age > 60 years

100%

100%

100%

100%

Male sex

42.8%

70.8%

65.7%

67.1%

Diabetes mellitus

0%

41.6

40.0%

38.5%

Serum creatinine (mg/dL)

0.75 ± 0.17

2.27 ± 0.55

4.80 ± 1.51

9.35 ± 2.23

eGFR (mL/min/1.73 m2)

67.6 ± 12.9

22.0 ± 4.9

9.8 ± 2.5

4.7 ± 1.2

Antibody titers (U/mL)

533 (275.5–1100)

358 (130.2–639.2)

218 (117–377)

185.5 (95.1–323.5)

Antibody positivity

100%

100%

100%

98.5%

Sample taken after second vaccination (days)

33 (23–45)

100 (79–127.5)

97 (84.7–110)

43 (36–50)

  1. Values are expressed as mean ± SD for continuous variables with normal distribution and as median rank (25th-75th percentiles) for continuous variables without normal distribution